Revision to German Pharmaceutical Act finalised and published
This article was originally published in SRA
Executive Summary
After massive criticism from the pharmaceutical industry, the revision to Germany’s Pharmaceutical Act was amended allowing the industry to keep at least a limited right to choose how and which wholesalers they supply. This compromise on the compulsory supply to wholesalers was reached following long and controversial debates.